Biome Grow Financials
| BIOIF Stock | USD 0 0.00 0.00% |
Biome |
Understanding current and past Biome Grow Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Biome Grow's financial statements are interrelated, with each one affecting the others. For example, an increase in Biome Grow's assets may result in an increase in income on the income statement.
Biome Grow Stock Summary
Biome Grow competes with Hypera SA, Cumberland Pharmaceuticals, Genomma Lab, Procyon, and Curaleaf Holdings. Biome Grow is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 1401-480 University Avenue, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.biomegrow.com |
| Phone | 416 875 8395 |
| Currency | USD - US Dollar |
Biome Grow Key Financial Ratios
There are many critical financial ratios that Biome Grow's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Biome Grow reports annually and quarterly.| Return On Equity | -4.37 | |||
| Return On Asset | -0.0844 | |||
| Beta | 0.41 |
Biome Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biome Grow's current stock value. Our valuation model uses many indicators to compare Biome Grow value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biome Grow competition to find correlations between indicators driving Biome Grow's intrinsic value. More Info.Biome Grow is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biome Grow's earnings, one of the primary drivers of an investment's value.Biome Grow Systematic Risk
Biome Grow's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Biome Grow volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Biome Grow correlated with the market. If Beta is less than 0 Biome Grow generally moves in the opposite direction as compared to the market. If Biome Grow Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Biome Grow is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Biome Grow is generally in the same direction as the market. If Beta > 1 Biome Grow moves generally in the same direction as, but more than the movement of the benchmark.
Biome Grow December 4, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Biome Grow help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Biome Grow. We use our internally-developed statistical techniques to arrive at the intrinsic value of Biome Grow based on widely used predictive technical indicators. In general, we focus on analyzing Biome Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Biome Grow's daily price indicators and compare them against related drivers.
| Downside Deviation | 44.84 | |||
| Information Ratio | 0.076 | |||
| Maximum Drawdown | 264.86 | |||
| Value At Risk | (48.65) | |||
| Potential Upside | 21.62 |
Complementary Tools for Biome Pink Sheet analysis
When running Biome Grow's price analysis, check to measure Biome Grow's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biome Grow is operating at the current time. Most of Biome Grow's value examination focuses on studying past and present price action to predict the probability of Biome Grow's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biome Grow's price. Additionally, you may evaluate how the addition of Biome Grow to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |